July 2015 FDA Recall Drug by Ucb, Inc
D-1348-2015 - Failed Dissolution Testing

This Class II drug recall was voluntarily initiated by Ucb, Inc on July 24, 2015 for the product Drug. The FDA reported the reason for recall as failed dissolution testing. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1348-2015

Reason for Recall
Failed Dissolution Testing: Failed 24 month dissolution testing.
Initiated
07-24-2015
Reported
08-26-2015
Quantity
2,916 Bottles

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
71986
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Ucb, Inc
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
U.S. Nationwide
Termination Date About Termination Date
Date that FDA officially terminated the recall.
07-19-2017
Product Description About Product Description
Full technical description of the product.
univasc (moexipril HCl) tablets, 7.5 mg, 100 Ct Bottle, Rx Only. Manufactured for UCB, Inc., Smyrna, GA 30080. NDC: 0091-3707-01.

Batch or Lot Expiration Information

Lot# : 98016P1, Expiry: April, 2016